BSE Live
Oct 24, 13:02Prev. Close
876.55
Open Price
878.00
Bid Price (Qty.)
872.25 (5)
Offer Price (Qty.)
876.95 (1)
NSE Live
Oct 25, 15:57Prev. Close
689.35
Open Price
691.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
672.25 (249)
| Cash Flow of Novartis India (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 130.42 | 122.84 | 115.38 | -3.82 | 40.04 | |
| Net CashFlow From Operating Activities | 74.57 | 113.40 | 44.80 | 38.67 | -69.21 | |
| Net Cash Used In Investing Activities | -3.31 | 33.13 | -153.25 | 87.04 | 95.16 | |
| Net Cash Used From Financing Activities | -64.15 | -120.99 | -30.48 | -35.63 | -36.80 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 7.11 | 25.54 | -138.93 | 90.08 | -10.85 | |
| Cash And Cash Equivalents Begin of Year | 44.96 | 19.42 | 158.35 | 68.27 | 79.12 | |
| Cash And Cash Equivalents End Of Year | 52.07 | 44.96 | 19.42 | 158.35 | 68.27 |
30.07.2025
Novartis India Standalone June 2025 Net Sales at Rs 87.55 crore, down 5.14% Y-o-Y
29.01.2025
Novartis India Standalone December 2024 Net Sales at Rs 93.00 crore, up 10.01% Y-o-Y
28.10.2024
Novartis India Standalone September 2024 Net Sales at Rs 87.10 crore, up 10.59% Y-o-Y
29.07.2024
Novartis India Standalone June 2024 Net Sales at Rs 92.29 crore, up 1.87% Y-o-Y